248 related articles for article (PubMed ID: 16891358)
1. Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.
PĂ©ron JM; Bureau C; Gourdy P; Lulka H; Souque A; Calippe B; Selves J; Al Saati T; Bernad J; Cordelier P; Couderc B; Pradayrol L; Pipy B; Buscail L; Vinel JP
Gut; 2007 Jan; 56(1):107-14. PubMed ID: 16891358
[TBL] [Abstract][Full Text] [Related]
2. Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12.
Peron JM; Couderc B; Rochaix P; Douin-Echinard V; Asnacios A; Souque A; Voigt JJ; Buscail L; Vinel JP; Favre G
J Gastroenterol Hepatol; 2004 Apr; 19(4):388-96. PubMed ID: 15012775
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
Colombo PE; Boustta M; Poujol S; Jarlier M; Bressolle F; Teulon I; Ladjemi MZ; Pinguet F; Rouanet P; Vert M
Gynecol Oncol; 2011 Sep; 122(3):632-40. PubMed ID: 21665252
[TBL] [Abstract][Full Text] [Related]
4. NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine.
Alkayyal AA; Tai LH; Kennedy MA; de Souza CT; Zhang J; Lefebvre C; Sahi S; Ananth AA; Mahmoud AB; Makrigiannis AP; Cron GO; Macdonald B; Marginean EC; Stojdl DF; Bell JC; Auer RC
Cancer Immunol Res; 2017 Mar; 5(3):211-221. PubMed ID: 28159747
[TBL] [Abstract][Full Text] [Related]
5. SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors.
Gonzalez-Junca A; Liu FD; Nagaraja AS; Mullenix A; Lee CT; Gordley RM; Frimannsson DO; Maller O; Garrison BS; Iyer D; Benabbas A; Truong TA; Quach A; Tian M; Martinez R; Savur R; Perry-McNamara A; Nguyen D; Almudhfar N; Blanco C; Huynh C; Nand A; Lay YE; Magal A; Mangalampalli S; Lee PJ; Lu TK; Lee G
Mol Cancer Ther; 2021 Sep; 20(9):1508-1520. PubMed ID: 34210826
[TBL] [Abstract][Full Text] [Related]
6. The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
Pasche N; Wulhfard S; Pretto F; Carugati E; Neri D
Clin Cancer Res; 2012 Aug; 18(15):4092-103. PubMed ID: 22693354
[TBL] [Abstract][Full Text] [Related]
7. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
[TBL] [Abstract][Full Text] [Related]
8. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM
Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073
[TBL] [Abstract][Full Text] [Related]
9. Treatment of peritoneal carcinomatosis with intraperitoneal administration of Ad-hARF.
Rajeshkumar BR; Paliwal S; Lambert L; Grossman SR; Whalen GF
J Surg Res; 2015 Jul; 197(1):85-90. PubMed ID: 25935465
[TBL] [Abstract][Full Text] [Related]
10. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
[TBL] [Abstract][Full Text] [Related]
11. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.
Miura Y; Ohnami S; Yoshida K; Ohashi M; Nakano M; Ohnami S; Fukuhara M; Yanagi K; Matsushita A; Uchida E; Asaka M; Yoshida T; Aoki K
Cancer Lett; 2005 Jan; 218(1):53-62. PubMed ID: 15639340
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy.
Sanches R; Kuiper M; Penault-Llorca F; Aunoble B; D'Incan C; Bignon YJ
Cancer Gene Ther; 2000 May; 7(5):707-20. PubMed ID: 10830718
[TBL] [Abstract][Full Text] [Related]
15. Block/homo polyplex micelle-based GM-CSF gene therapy via intraperitoneal administration elicits antitumor immunity against peritoneal dissemination and exhibits safety potentials in mice and cynomolgus monkeys.
Ohgidani M; Furugaki K; Shinkai K; Kunisawa Y; Itaka K; Kataoka K; Nakano K
J Control Release; 2013 May; 167(3):238-47. PubMed ID: 23422727
[TBL] [Abstract][Full Text] [Related]
16. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2.
Bevanda M; Orsolic N; Basic I; Vukojevic K; Benkovic V; Horvat Knezevic A; Lisicic D; Dikic D; Kujundzic M
Int J Hyperthermia; 2009 Mar; 25(2):132-40. PubMed ID: 19337913
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene.
Hwang RF; Gordon EM; Anderson WF; Parekh D
Surgery; 1998 Aug; 124(2):143-50; discussion 150-1. PubMed ID: 9706132
[TBL] [Abstract][Full Text] [Related]
18. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
19. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma.
Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K
Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165
[TBL] [Abstract][Full Text] [Related]
20. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]